Show simple item record

dc.contributor.authorMatutes, Een_US
dc.date.accessioned2018-07-13T10:43:19Z
dc.date.issued2010-07en_US
dc.identifierhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895036/en_US
dc.identifier.citationHAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (7), pp. 1122 - 1129en_US
dc.identifier.issn0390-6078en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2058
dc.description.abstractBackground Splenic diffuse red pulp small B-cell lymphoma is an uncommon B-cell lymphoma, now recognized as a provisional entity in the 2008 update of the WHO Classification. Additional work is required to review this entity and establish its diagnostic features. Design and Methods We have retrospectively analyzed the disease features in a highly selected series of 17 patients diagnosed as splenic diffuse red pulp small B-cell lymphoma. Results The median age was 65.5 years (range 40-79 years) and there was a predominance of males (male/female ratio: 2.4). Clinical manifestations were mainly derived from splenomegaly. Splenectomy was the front-line treatment in 11 symptomatic patients; the remaining 6 received chemotherapy initially followed by splenectomy. After a mean follow-up of 72 months, the five-year overall survival was 93%. All cases showed a purely diffuse pattern of splenic infiltration by monomorphous small cells with small round nuclei and pale cytoplasm. All bone marrow biopsies showed tumoral infiltration, with intrasinusoidal infiltration. Peripheral blood cells were small to medium-sized, with clumped chromatin and round nuclear outline and villous cytoplasm. Neoplastic cells had a CD20(+), CD23(-), bcl6(-), Arinexin A1- phenotype, with frequent expression of DBA44+ (15/17) and IgG (10/15). FCM data had a B-cell phenotype (CD19(+), CD20(+), CD22(+)) with FMC7 (10/11) and CD11c (5/8) expression. Clonal IgH rearrangement studies in 4 cases showed IgVH mutations in all cases, without VH1.2 usage. Conclusions Our data suggest that splenic diffuse red pulp small B-cell lymphoma is a distinct entity with morphological and immunophenotypical features that differ from those of other splenic lymphomas.en_US
dc.format.extent1122 - 1129en_US
dc.publisherFERRATA STORTI FOUNDATIONen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectsplenic lymphoma; leukemia; villous cells;MARGINAL-ZONE LYMPHOMA; VILLOUS LYMPHOCYTES; LEUKEMIA; VARIANT; DELETION; DISTINCTen_US
dc.titleSplenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological featuresen_US
dc.typeJournal Article
rioxxterms.licenseref.startdate2010-07en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfHAEMATOLOGICA-THE HEMATOLOGY JOURNALen_US
pubs.issue7en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Molecular Haematology (including Cytogenetics Group and Cell Markers)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular Haematology (including Cytogenetics Group and Cell Markers)
pubs.volume95en_US
pubs.embargo.termsNot knownen_US
icr.researchteamMolecular Haematology (including Cytogenetics Group and Cell Markers)en_US
dc.contributor.icrauthorMatutes, Estellaen_US
dc.contributor.icrauthorWotherspoon, Andrewen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/